XTANT MEDICAL (Germany) Probability of Future Stock Price Finishing Over 12.86
| XMS Stock | EUR 0.34 0.01 3.03% |
XTANT |
XTANT MEDICAL Target Price Odds to finish over 12.86
The tendency of XTANT Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 12.86 or more in 90 days |
| 0.34 | 90 days | 12.86 | close to zero percent |
Based on a normal probability distribution, the odds of XTANT MEDICAL to move over € 12.86 or more in 90 days from now is close to zero percent (This XTANT MEDICAL HLDGS probability density function shows the probability of XTANT Stock to fall within a particular range of prices over 90 days) . Probability of XTANT MEDICAL HLDGS price to stay between its current price of € 0.34 and € 12.86 at the end of the 90-day period is about 84.75 .
Assuming the 90 days horizon XTANT MEDICAL HLDGS has a beta of -0.31. This entails as returns on the benchmark increase, returns on holding XTANT MEDICAL are expected to decrease at a much lower rate. During a bear market, however, XTANT MEDICAL HLDGS is likely to outperform the market. Additionally XTANT MEDICAL HLDGS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. XTANT MEDICAL Price Density |
| Price |
Predictive Modules for XTANT MEDICAL
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as XTANT MEDICAL HLDGS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.XTANT MEDICAL Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. XTANT MEDICAL is not an exception. The market had few large corrections towards the XTANT MEDICAL's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold XTANT MEDICAL HLDGS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of XTANT MEDICAL within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.36 | |
β | Beta against Dow Jones | -0.31 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | -0.08 |
XTANT MEDICAL Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of XTANT MEDICAL for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for XTANT MEDICAL HLDGS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| XTANT MEDICAL HLDGS generated a negative expected return over the last 90 days | |
| XTANT MEDICAL HLDGS has some characteristics of a very speculative penny stock | |
| XTANT MEDICAL HLDGS has high historical volatility and very poor performance | |
| XTANT MEDICAL HLDGS has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 56.67 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 32.49 M. | |
| Over 75.0% of the company outstanding shares are owned by institutional investors |
XTANT MEDICAL Technical Analysis
XTANT MEDICAL's future price can be derived by breaking down and analyzing its technical indicators over time. XTANT Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of XTANT MEDICAL HLDGS. In general, you should focus on analyzing XTANT Stock price patterns and their correlations with different microeconomic environments and drivers.
XTANT MEDICAL Predictive Forecast Models
XTANT MEDICAL's time-series forecasting models is one of many XTANT MEDICAL's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary XTANT MEDICAL's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about XTANT MEDICAL HLDGS
Checking the ongoing alerts about XTANT MEDICAL for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for XTANT MEDICAL HLDGS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| XTANT MEDICAL HLDGS generated a negative expected return over the last 90 days | |
| XTANT MEDICAL HLDGS has some characteristics of a very speculative penny stock | |
| XTANT MEDICAL HLDGS has high historical volatility and very poor performance | |
| XTANT MEDICAL HLDGS has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 56.67 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 32.49 M. | |
| Over 75.0% of the company outstanding shares are owned by institutional investors |
Other Information on Investing in XTANT Stock
XTANT MEDICAL financial ratios help investors to determine whether XTANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTANT with respect to the benefits of owning XTANT MEDICAL security.